You can buy or sell Edesa Biotech and other stocks, options, and ETFs commission-free!
Edesa Biotech, Inc. Common Shares, also called Edesa Biotech, is a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. The company product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded on June 12, 2007 and is headquartered in Markham, Canada. The listed name for EDSA is Edesa Biotech, Inc. Common Shares.
52 Week High
52 Week Low
— per share
Expected Feb 28, Pre-Market